Organisation mondiale de la santé (OMS) · Technical documents

Regional framework for action to strengthen the public health response to substance use

Organisation mondiale de la santé
Voir le document original

Le texte intégral est hébergé par l’organisation qui le publie. lawenc.com indexe les métadonnées et renvoie vers la source officielle.

Texte intégral

Resolution

REGIONAL COMMITTEE FOR THE EM/RC66/R.7

EASTERN MEDITERRANEAN October 2019

Sixty-sixth Session Agenda item 3(f)

Regional framework for action to strengthen the public health response to substance use

The Regional Committee,

Having reviewed the technical paper presenting a draft regional framework for action to strengthen the

public health response to substance use;1

Recalling Resolution A/RES/S-30/1 “Our joint commitment to effectively addressing and countering

the world drug problem”, adopted by the 2016 United Nations General Assembly in its special session

(UNGASS) on the world drug problem;

Taking into account Target 3.5 of SDG 3: “strengthen the prevention and treatment of substance abuse,

including narcotic drug abuse and harmful use of alcohol”;2

Recognizing that substance use poses a large and growing challenge to public health and economic

development in all parts of the world, including the Eastern Mediterranean Region;

Mindful that a number of countries in the Region face complex emergencies which render their

populations – especially adolescents, women and young adults – particularly vulnerable to substance

use problems;

Noting that although cost-effective and evidence-based interventions are available, only one person in

every 13 with a substance use disorder in the Region receives treatment;

Recognizing that there is a need for a framework to operationalize the recommendations made in the

UNGASS 2016 outcome document to strengthen the public health response to substance use;

1. ENDORSES the regional framework for action to strengthen the public health response to

substance use (which is annexed to this resolution);

2. URGES Member States to implement the strategic interventions identified in the regional

framework with special emphasis on:

1 EM/RC66/8. 2 United Nations General Assembly resolution 66/288.

- 2 -

2.1 Developing, reviewing and updating national policies and legislation through a multisectoral

approach, to minimize the adverse public health and social consequences of substance use;

2.2 Enhancing the availability, coverage and quality of prevention measures and tools, based on

scientific evidence, that target relevant age and risk groups in multiple settings;

2.3 Scaling up coverage through effective drug treatment, care, rehabilitation, recovery and

social reintegration programmes, giving special attention to those in vulnerable situations;

2.4 Developing and strengthening the capacity of health and social care professionals to provide

interventions based on scientific evidence, including appropriate medication-assisted therapy

programmes and other relevant interventions;

2.5 Integrating the core set of indicators within their national health information systems to

enable reporting on the relevant SDG indicator(s);

3. REQUESTS the Regional Director to:

3.1 Provide technical support to Member States to implement and monitor the strategic actions

listed in the regional framework;

3.2 Support Member States to enhance their capacity to undertake and utilize operational

research and generate reliable and comparable data;

3.3 Facilitate the development of regional networks for the regular exchange of information,

good practice and lessons learned among Member States;

3.4 Report on progress made in implementing the regional framework to the 68th and 70th

sessions of the Regional Committee, with a final report to the 72nd session.

- 3 -

Annex 1. Regional framework for action to strengthen the public health response to substance use

Domain Strategic interventions Indicators

Governance • Include evidence-based, cost-effective interventions in the universal health coverage priority benefit package

• Develop/update evidence-informed national substance use policies with a strong public health component, in consultation with stakeholders from the public, private and civil society sectors

• Develop/update substance use-related legislation(s) in line with international covenants, treaties and conventions, in consultation with stakeholders from the public, private and civil society sectors

• Set up an intersectoral coordination mechanism to facilitate the implementation and monitoring of evidence-based substance use policies and legislation

• Allocate specific budget allocations within the health and welfare sectors to address the prevention, management, rehabilitation, recovery, and monitoring and evaluation of substance use disorders

• Develop programmes offering alternatives to incarceration for drug offenders

• Operational multisectoral public health-oriented substance use policies are endorsed and published

• Relevant national legislation(s) is updated in line with international covenants, treaties and conventions

• Intersectoral (inter-ministerial) coordinating mechanism is in place reflecting public health leadership

• Specified budgetary allocations are in place to cover the prevention, treatment, care and rehabilitation of substance use disorders

• Depenalization/decriminalization of drug use, and drug courts are available in major cities

• Treatment services for substance use disorders and related health problems are available for incarcerated populations across the continuum of care

Health sector response

• Integrate screening and brief interventions for substance use disorders and management of overdose within primary health care and emergency rooms (intervention packages)

• Develop/strengthen specialized services for the holistic and integrated management of substance use disorders, including pharmacological and psychosocial interventions

• Introduce and/or rapidly scale up the comprehensive package of services for harm reduction (needle and syringe exchange schemes, opioid substitution treatment, voluntary counselling and testing for HIV/hepatitis C, hepatitis B vaccination, antiretroviral therapy, tuberculosis care and treatment, sexually transmitted infection diagnosis and management, and overdose prevention and management)

• Ensure that essential medicines for the management of substance use disorders are available

• Develop the capacity of health and social welfare personnel in substance use prevention, treatment, care and rehabilitation by integrating it into pre- and in-service teaching/training and as a part of continuing professional education/recertification processes

• Facilitate and promote the establishment of self-help and mutual aid groups

• Develop/strengthen capacity to conduct and utilize implementation research

• Primary health care and emergency services staff are trained to deliver screening and brief interventions for substance use disorders and to manage opioid overdose

• Multidisciplinary specialist teams are available for out- and inpatient treatment and care of substance use disorders, including the provision of pharmacological and psychosocial interventions

• Referral guidelines and pathways between primary and specialist services are in place

• United Nations Office on Drugs and Crime (UNODC)/WHO treatment standards for ensuring quality are adopted/adapted

• A comprehensive package of services for harm reduction is in place

• Methadone, buprenorphine, naloxone and other medications for detoxification and maintenance treatment are available as a part of a comprehensive package for the management of substance use disorders

• A substance use component is integrated into pre- and in-service education/training programmes for health and social welfare professionals and in continuing professional education/recertification programmes

• Self-help/mutual aid groups are available

• National and regional networks are established to undertake priority implementation research, including a focus on complex emergency situations

Promotion and prevention

• Embed universal substance use prevention programmes within broader health policies and strategies based on rigorous local needs and resource assessment

• Design and implement age-specific substance use prevention programmes in community, education and workplace settings

• Multicomponent community intervention programmes are available, including parenting skills and family strengthening programmes

• Life skills education programmes are integrated into school curricula

• Workplace education and intervention programmes are in place

• Targeted campaigns are developed using multiple media channels to improve literacy about substance use and substance use disorders

• Updated UNODC/WHO prevention standards for ensuring quality are adopted/adapted

- 4 -

Domain Strategic interventions Indicators

Monitoring and surveillance

• Identify a standard set of comparable core indicators (guided by the Lisbon consensus)* to monitor the substance use situation, including for inclusion in existing surveys

• Develop a national substance use monitoring and surveillance system to collect and report on the core set of indicators using standard data collection tools and methodologies

• National monitoring and surveillance systems are in place

• Regular reports are published and shared with national/international stakeholders and partners using the core set of indicators

• Monitoring and registration systems are in place for prescription drugs

International cooperation

• Promote the active sharing of information and evidence between professionals and civil society organizations from countries of the Region at national and international policy forums on substance use

• A regional network to coordinate the public health response to substance use is activated and facilitated

*United Nations Commission on Narcotic Drugs, United Nations Economic and Social Council. Drug information systems: principles, structures and indicators. Vienna: United Nations

Commission on Narcotic Drugs; 2000 (E/CN.7/2000/CRP.3; https://www.unodc.org/documents/data-and-analysis/statistics/Drugs/lisbon_consensus.pdf, accessed 14 July 2019).

Informations clés
Type de document Technical documents
Date d'adoption
Source Organisation mondiale de la santé